Cote d'Ivoire vs Ghana: Cause of death, by non-communicable diseases, ages 60+, female
Cote d'Ivoire
68.1%
in 2021
Ghana
68.4%
in 2021
Cote d'Ivoire rank
133rd
Ghana rank
131st
Cause of death, by non-communicable diseases, ages 60+, female over time
- Cote d'Ivoire
- Ghana
How they compare
Ghana currently reports 68.4% against 68.1% in Cote d'Ivoire, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Ghana ahead.
Cote d'Ivoire ranks 133rd and Ghana ranks 131st of 185 countries.
Ghana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 65.5% | 15.5% | Ghana |
| 2010s | 71.2% | 71.6% | 0.4% | Ghana |
| 2020s | 69.2% | 69.6% | 0.3% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Cote d'Ivoire or Ghana?
- Ghana, at 68.4% against 68.1% in Cote d'Ivoire as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Cote d'Ivoire and Ghana?
- 0.3%, with Ghana ahead.
- How many years of comparable data are there for Cote d'Ivoire and Ghana?
- 6 years are reported by both, from 2000 to 2021.
- How do Cote d'Ivoire and Ghana rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Cote d'Ivoire ranks 133rd and Ghana ranks 131st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.